Heumann Pharma Gmbh CO. Generica KG Pharmaceutical Import Profile — Germany (DGFT 2022–2026)

Name: Heumann Pharma Gmbh CO. Generica KG Pharmaceutical Import Records from India — 3 Products, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Heumann Pharma Gmbh CO. Generica KG — Pharmaceutical Importer Profile (2026) | 3 Products, $1.4M Trade | TransData Nexus

Heumann Pharma Gmbh CO. Generica KG

Pharmaceutical Importer · Germany · Lipid & Metabolism Focus · $1.4M Total Trade · DGFT Verified

Heumann Pharma Gmbh CO. Generica KG is a pharmaceutical importer based in Germany with a total trade value of $1.4M across 3 products in 3 therapeutic categories. Based on 36 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Heumann Pharma Gmbh CO. Generica KG sources from 1 verified Indian supplier, with Torrent Pharmaceuticals Limited accounting for 100.0% of imports.

Heumann Pharma Gmbh CO. Generica KG — Import Portfolio & Supplier Network

Heumann Pharma Gmbh CO. Generica KG import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Heumann Pharma Gmbh CO. Generica KG?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Torrent Pharmaceuticals Limited	$23.9M	1,199	100.0%

Heumann Pharma Gmbh CO. Generica KG sources from 1 verified Indian supplier across 867 distinct formulations. The sourcing is highly concentrated — Torrent Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Other-candesartan /hct heumann	$414.0K	9
Other - rosuvastatin heumann 20 MG filmtabletten tablet ( rosuvastatin calcium20mg ) nos size 10x10	$333.3K	8
Other-aciclovir 800 heumann tablet ( aciclovir 800MG ) nos size 5 x 7	$254.3K	8
Other - quetiapin heumann 25MG film	$191.9K	8
Other - escitalopram heumann 10 MG	$187.6K	5
Other-candesartan /hct heumann 16MG/12.5MG tabletten ( candesartan cilexetil tablets 16MG + hctz 12.5MG )	$180.3K	6
Candesartan /hct heumann 16MG/12.5MG tabletten (candesartan cilexetil tablets 16MG + hctz 12.5MG )	$177.8K	5
Other-aciclovir 400 heumann tablet ( aciclovir 400MG ) nos size 7 x 10	$153.5K	5
Other -mirtazapin heumann 30MG filmtabletten ( mirtazapin 30MG ) nos size 10 x10	$151.7K	4
Other - pantoprazol heumann 40MG magensaftresistente tabletten ( pantoprazole 40MG ) nos size 10x10	$147.4K	7
Other - quetiapin heumann 150MG film tabletten ( quetiapine 150MG ) nos size 10x10	$139.1K	3
Other - amiodaron 200 heumann tabletten( amiodarone hydrochloride 200MG ) nos size 10x10	$137.8K	3
Other - rosuvastatin heumann 10 MG	$136.8K	4
Other-olanzapin heumann 20 MG schmelztabletten ( olanzapine 20MG ) nos size 10 x7	$133.7K	3
Losartan comp heu 100MG/25MG filmtabletten (losartan potassium 100MG +hydrochlorothiazide 25MG) nos size 7 x 14	$132.2K	3

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Allopurinol	Lipid & Metabolism	$750.0K	15	0.2%	12
2	Amiodarone	Cardiovascular	$496.6K	11	0.7%	12
3	Roxithromycin	Advanced Antibiotics	$159.7K	10	3.8%	6

Heumann Pharma Gmbh CO. Generica KG imports 3 pharmaceutical products across 3 categories into Germany totaling $1.4M.

Heumann Pharma Gmbh CO. Generica KG — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Heumann Pharma GmbH & Co. Generica KG, established in 1913 by Pastor Ludwig Heumann, is a prominent pharmaceutical company headquartered in Nuremberg, Germany. The company specializes in the wholesale distribution of pharmaceutical products, offering a diverse portfolio that includes over 160 prescription medicines and more than 25 over-the-counter remedies. This extensive range enables Heumann Pharma to address a wide array of medical conditions, reflecting its commitment to providing affordable and accessible healthcare solutions. (heumann.de)

In 2005, Heumann Pharma became part of the Torrent Pharmaceuticals Group, a globally active pharmaceutical company headquartered in Ahmedabad, India. This strategic acquisition has bolstered Heumann Pharma's capabilities, ensuring the delivery of high-quality pharmaceutical products to the German market. (heumann.de) The company's dedication to affordability and quality has solidified its position as a key player in Germany's pharmaceutical distribution landscape.

2Distribution Network

Heumann Pharma GmbH & Co. Generica KG operates from its headquarters in Nuremberg, Germany. While specific details about its warehouse locations and logistics capabilities are not publicly disclosed, the company's extensive product portfolio and significant market presence suggest a well-established distribution network. This network is likely designed to ensure efficient delivery of pharmaceutical products across Germany and potentially to other European markets.

3Industry Role

Heumann Pharma GmbH & Co. Generica KG plays a pivotal role in Germany's pharmaceutical supply chain as a primary wholesaler and distributor. The company focuses on the wholesale distribution of pharmaceutical goods, offering a wide range of prescription and over-the-counter medicines. Its strategic emphasis on participating in tenders with statutory and private health insurance companies has significantly contributed to its growth and success in the German market. (heumann.de)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Heumann Pharma Gmbh CO. Generica KG

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Heumann Pharma's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from India. This concentrated sourcing approach can offer benefits such as cost efficiency and streamlined supply chain management. However, it also introduces potential risks, including exposure to supply disruptions and currency fluctuations. The company's reliance on a single supplier, Torrent Pharmaceuticals Limited, for its imports from India underscores the importance of maintaining a stable and reliable relationship to mitigate these risks.

2Supply Chain Resilience

The resilience of Heumann Pharma's supply chain is closely tied to its relationship with Torrent Pharmaceuticals Limited. While the company imports a diverse range of formulations from India, the heavy reliance on a single supplier could pose challenges in the event of supply chain disruptions. To enhance resilience, Heumann Pharma may consider diversifying its supplier base and establishing contingency plans to address potential disruptions. Ensuring that suppliers adhere to recognized quality standards, such as EU GMP, is crucial for maintaining the integrity and reliability of the supply chain.

Strategic Implications

Importing Pharmaceuticals into Germany — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Germany

1Regulatory Authority & Framework

In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) serves as the primary regulatory authority overseeing the approval and monitoring of pharmaceutical products. The Medicines Act (Arzneimittelgesetz) and the Medical Devices Act (Medizinproduktegesetz) are key pieces of legislation governing the importation, marketing, and distribution of pharmaceutical products in Germany. For Indian generics to be marketed in Germany, they must undergo a centralized marketing authorization procedure through the European Medicines Agency (EMA), ensuring compliance with EU standards.

2Import Licensing & GMP

Importers like Heumann Pharma GmbH & Co. Generica KG must obtain an import license from the BfArM to legally import pharmaceutical products into Germany. Additionally, imported products must be manufactured in facilities that comply with Good Manufacturing Practice (GMP) standards recognized by the European Union, such as EU GMP, WHO GMP, or PIC/S certifications. Heumann Pharma must also hold a wholesale distribution authorization, ensuring that all imported products are handled, stored, and distributed in accordance with German regulations.

3Quality & Labeling

Heumann Pharma Gmbh CO. Generica KG — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Heumann Pharma GmbH & Co. Generica KG's focus on therapeutic categories such as Lipid & Metabolism, Cardiovascular, and Advanced Antibiotics aligns with prevalent health concerns in Germany. The significant importation of Allopurinol, Amiodarone, and Roxithromycin indicates a strategic emphasis on addressing chronic conditions and infections. Market demand for affordable and effective treatments in these areas drives the company's import strategy, reflecting its commitment to meeting the healthcare needs of the German population.

2Sourcing Profile

Heumann Pharma's sourcing strategy is centered on importing finished pharmaceutical formulations from India, particularly from Torrent Pharmaceuticals Limited. This approach allows the company to offer a wide range of generic medicines at competitive prices. By focusing on finished products, Heumann Pharma can ensure quality control and compliance with German regulatory standards, while also benefiting from the cost advantages associated with sourcing from India.

3Market Positioning

Heumann Pharma GmbH & Co. Generica KG serves the German pharmaceutical market by supplying generic medicines to various segments, including retail pharmacies, hospitals, and government tenders. Its extensive product portfolio and strategic focus on tenders with health insurance companies enable the company to cater to a broad spectrum of healthcare providers and patients, reinforcing its position in the wholesale distribution segment.

Seller's Guide — How to Become a Supplier to Heumann Pharma Gmbh CO. Generica KG

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter Heumann Pharma's supply chain by meeting the company's stringent quality standards and regulatory requirements. Diversifying Heumann Pharma's supplier base could enhance supply chain resilience and reduce dependency on a single source. Indian exporters can explore this opportunity by ensuring compliance with EU GMP standards and establishing reliable supply capabilities.

2Requirements & Qualifications

Indian exporters seeking to supply Heumann Pharma GmbH & Co. Generica KG must obtain GMP certifications recognized by the European Union, such as EU GMP, WHO GMP, or PIC/S. Additionally, they must comply with German import licensing requirements and ensure that their products meet the labeling and serialization standards mandated by German regulations. Adhering to these requirements is essential for establishing a successful partnership with Heumann Pharma.

3How to Approach

Frequently Asked Questions — Heumann Pharma Gmbh CO. Generica KG

What products does Heumann Pharma Gmbh CO. Generica KG import from India?

Heumann Pharma Gmbh CO. Generica KG imports 3 pharmaceutical products across 3 categories. Top imports: Allopurinol ($750.0K), Amiodarone ($496.6K), Roxithromycin ($159.7K).

Who supplies pharmaceuticals to Heumann Pharma Gmbh CO. Generica KG from India?

Heumann Pharma Gmbh CO. Generica KG sources from 1 verified Indian suppliers. The primary supplier is Torrent Pharmaceuticals Limited (100.0% of imports, $23.9M).

What is Heumann Pharma Gmbh CO. Generica KG's total pharmaceutical import value?

Heumann Pharma Gmbh CO. Generica KG's total pharmaceutical import value from India is $1.4M, based on 36 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Heumann Pharma Gmbh CO. Generica KG focus on?

Heumann Pharma Gmbh CO. Generica KG imports across 3 categories. The largest: Lipid & Metabolism (53.3%), Cardiovascular (35.3%), Advanced Antibiotics (11.4%).

Get Full Heumann Pharma Gmbh CO. Generica KG Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.